Optimizing treatment with opioids and beyond

Advances in Psychosomatic Medicine

Volumn 30, Issue , 2011, Pages 92-112

  Clark, Michael R ^a,c   Treisman, Glenn J ^a,b,c,d  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Chronic Pain Treatment Program   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ARTICLE; CHRONIC DISEASE; COMORBIDITY; HUMAN; MENTAL DISEASE; OPIATE ADDICTION; PAIN; PATIENT CARE PLANNING; TREATMENT OUTCOME;

ANALGESICS, OPIOID; CHRONIC DISEASE; COMORBIDITY; HUMANS; MENTAL DISORDERS; OPIOID-RELATED DISORDERS; PAIN; PATIENT CARE PLANNING; TREATMENT OUTCOME;

EID: 79955747461     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324068     Document Type: Article

References (147)

1. Fleming M, Balousek S, Klessig C, Mundt M, Brown D: Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 2007;8: 573-582. (Pubitemid 46991033)
2. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK: Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003;289:2370-2378. (Pubitemid 37430169)
3. Peles E, Schreiber S, Gordon J, Adelson M: Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain 2005;113:340-346. (Pubitemid 40127516)
4. Nickel R, Raspe HH: Chronic pain: epidemiology and health care utilization (in German). Nervenarzt 2001;72:897-906.
5. Ospina M, Harstall C: Prevalence of chronic pain: an overview. Health Technology Assessment Report No 29. 2002. http://www.ihe.ca/hta/publications. html.
6. Verhaak PF, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM: Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain 1998; 77:231-239. (Pubitemid 28451511)
7. Elliott AM, Smith BH, Hannaford PC, Smith WC, Chambers WA: The course of chronic pain in the community: results of a 4-year follow-up study. Pain 2002;99:299-307. (Pubitemid 35247553)
8. Mäntyselkä PT, Turunen JH, Ahonen RS, Kumpusalo EA: Chronic pain and poor self-rated health. JAMA 2003;290:2435-2442. (Pubitemid 37430543)
9. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R: Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003;290:2443-2454. (Pubitemid 37430544)
10. Brands B, Blake J, Sproule B, Gourlay D, Busto U: Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend 2004;73:199-207. (Pubitemid 38068356)
11. Dowling LS, Gatchel RJ, Adams LL, Stowell AW, Bernstein D: An evaluation of the predictive validity of the Pain Medication Questionnaire with a heterogeneous group of patients with chronic pain. J Opioid Manag 2007;3:257-266.
12. Mertens JR, Lu Y W, Parthasarathy S, Moore C, Weisner CM: Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med 2003;163:2511-2517. (Pubitemid 37385795)
13. Portenoy RK, Dole V, Joseph H, Lowinson J, Rice C, Segal S, Richman BL: Pain management and chemical dependency: evolving perspectives. JAMA 1997; 278:592-593. (Pubitemid 27353610)
14. Scimeca MM, Savage SR, Portenoy R, Lowinson J: Treatment of pain in methadone-maintained patients. Mt Sinai J Med 2000;67:412-422.
15. Cohen MJ, Jasser S, Herron PD, Margolis CG: Ethical perspectives: opioid treatment of chronic pain in the context of addiction. Clin J Pain 2002; 18(suppl 4):S99-S107. (Pubitemid 34815400)
16. Drug Enforcement Administration: A joint statement from 21 health organizations and the Drug Enforcement Administration. Promoting pain relief and preventing abuse of pain medications: a critical balancing act. J Pain Symptom Manage 2002;24:147.
17. Nicholson B: Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63: 17-32. (Pubitemid 36132511)
18. Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K: Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend 2004;73:23-31. (Pubitemid 37542475)
19. Compton P, Darakjian J, Miotto K: Screening for addiction in patients with chronic pain and 'problematic' substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 1998;16:355-363. (Pubitemid 29006198)
20. Miotto K, Compton P, Ling W, Conolly M: Diagnosing addictive disease in chronic pain patients. Psychosomatics 1996;37:223-235. (Pubitemid 26131984)
21. Robinson RC, Gatchel RJ, Polatin P, Deschner M, Noe C, Gajraj N: Screening for problematic prescription opioid use. Clin J Pain 2001;17:220-228. (Pubitemid 32906541)
22. Savage SR: Assessment for addiction in pain-treatment settings. Clin J Pain 2002;18:S28-S38. (Pubitemid 34815392)
23. Højsted J, Sjøgren P: Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007;11: 490-518. (Pubitemid 46670780)
24. Portenoy RK: Opioid therapy for chronic nonmalig-nant pain: a review of the critical issues. J Pain Symptom Manage 1996;11:203-217. (Pubitemid 26102522)
25. Passik SD, Kirsh KL: Managing pain in patients with aberrant drug-taking behaviors. J Support Oncol 2005;3:83-86. (Pubitemid 41029591)
26. Passik SD, Kirsh KL, Whitcomb L, Schein JR, Kaplan MA, Dodd SL, Kleinman L, Katz N P, Portenoy RK: Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool. J Opioid Manag 2005;1:257-266.
27. Portenoy RK: Appropriate use of opioids for persistent non-cancer pain. Lancet 2004;364:739-740. (Pubitemid 39165083)
28. Savage SR: Addiction in the treatment of pain: significance, recognition and management. J Pain Symptom Manage 1993;8:265-278. (Pubitemid 23191390)
29. Sees KL, Clark HW: Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage 1993;8:257-264. (Pubitemid 23191389)
30. Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Muñoz A: The development of a comprehensive risk-management program for prescription opioid analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS). Pain Med 2007;8:157-170.
31. Olsen Y, Daumit GL, Ford DE: Opioid prescriptions by US primary care physicians from 1992 to 2001. J Pain 2006;7:223-235.
32. Gilson AM, Ryan KM, Joranson DE, Dahl JL: A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 2004; 28:176-188. (Pubitemid 38970078)
33. Cicero TJ, Inciardi JA, Muñoz A: Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. J Pain 2005;6:662-672. (Pubitemid 41395058)
34. Cicero TJ, Inciardi JA, Surratt H: Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States. Drug Alcohol Depend 2007;91:115-120. (Pubitemid 47539720)
35. Lamb E: Top 200 prescription drugs of 2007. Pharm Times 2008;74:20-23.
36. Smith MY, Schneider MF, Wentz A, Hughes A, Haddox JD, Dart R: Quantifying morbidity associated with the abuse and misuse of opioid analgesics: a comparison of two approaches. Clin Toxicol 2007; 45:23-30.
37. Cicero TJ, Inciardi JA: Diversion and abuse of meth-adone prescribed for pain management. JAMA 2005;293:297-298. (Pubitemid 40116082)
38. Brown RL, Patterson JJ, Rounds LA, Papasouliotis O: Substance abuse among patients with chronic back pain. J Fam Pract 1996;43:152-160. (Pubitemid 26274979)
39. Aronoff GM: Opioids in chronic pain management: is there a significant risk of addiction? Curr Rev Pain 2000;4:112-121.
40. Fishbain D, Cutler R, Rosomoff H: Comorbid psychiatric disorders in chronic pain patients. Pain Clin 1998;11:79-87.
41. Portenoy RK, Foley KM: Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171-186. (Pubitemid 16121641)
42. Taub A: Opioid analgesics in the treatment of chronic intractable pain on non-neoplastic origin; in Kitahata LM, Collins D (eds): Narcotic Analgesics in Anesthesiology. Baltimore, Williams and Wilkins, 1982, pp 199-208.
43. Jamison RN, Kauffman J, Katz NP: Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000;19:53-62. (Pubitemid 30067624)
44. Larson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, Samet JH: Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction 2007;102: 752-760. (Pubitemid 46633356)
45. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS: What percentage of chronic nonma-lignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008;9:444-459. (Pubitemid 351722518)
46. Moore TM, Jones T, Browder JH, Daffron S, Passik SD: A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med 2009;10:1426-1433.
47. Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, Palombi D, Jamison RN: Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage 2004;28:250-258. (Pubitemid 39158807)
48. Højsted J, Nielsen PR, Guldstrand SK, Frich L, Sjøgren P: Classification and identification of opi-oid addiction in chronic pain patients. Eur J Pain 2010;14:1014-1020.
49. Kirsh KL, Whitcomb LA, Donaghy K, Passik SD: Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain 2002;18:S52-S60. (Pubitemid 34815394)
50. Weaver M, Schnoll S: Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain 2002;18:S61-S69. (Pubitemid 34815395)
51. Potter JS, Hennessy G, Borrow JA, Greenfield SF, Weiss RD: Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend 2004;76: 213-215. (Pubitemid 39370817)
52. Eisenberg E, McNicol ED, Carr DB: Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005;293:3043-3052. (Pubitemid 40965075)
53. Furlan AD, Sandoval JA, Mallis-Gagnon A, Tunks E: Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J 2006;174:1589-1594. (Pubitemid 43829515)
54. Noble M, Tregear SJ, Treadwell JR, Schoelles K: Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage 2008;35: 214-228.
55. Devulder J, Richarz U, Nataraja SH: Impact of long-term use of opioids on quality of life in patients with chronic nonmalignant pain. Curr Med Res Opin 2005;84:S42-S55.
56. Ballantyne JC, Mao J: Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-1953. (Pubitemid 37409712)
57. Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK: Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006;125: 172-179. (Pubitemid 44498976)
58. Fields HL: Should we be reluctant to prescribe opi-oids for chronic non-malignant pain? Pain 2007;129: 233-234. (Pubitemid 46754579)
59. Kalso E, Edwards JE, Moore RA, McQuay HJ: Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-380. (Pubitemid 39550738)
60. Franklin GM, Mai J, Wickizer T, Turner JA, Fulton-Kehoe D, Grant L: Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. Am J Ind Med 2005;48: 91-99. (Pubitemid 41134211)
61. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK: Opioids for chronic non-cancer pain: prediction and identification of aberrant drug-related behaviors -a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131-146.
62. Passik SD, Kirsh KL, Donaghy KB, Portenoy RK: Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain 2006;22:173-181. (Pubitemid 44366968)
63. von Korff M, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, Sullivan MD, Rutter CM, Silverberg MJ, Banta-Green C, Weisner C: De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008;24:521-527.
64. McCracken LM, Hoskins J, Eccleston C: Concerns about medication and medication use in chronic pain. J Pain 2006;7:726-734. (Pubitemid 44466691)
65. Schieffer BM, Pham Q, Labus J, Baria A, van Vort W, Davis P, Davis F, Naliboff BD: Pain medication beliefs and medication misuse in chronic pain. J Pain 2005;6:620-629.
66. Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Amsten JH: The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manage 2004;28: 517-525. (Pubitemid 39422491)
67. Sullivan MD, von Korff M, Banta-Green C, Merrill JO, Saunders K: Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain 2010;149:345-353.
68. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM: Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;20:CD006605.
69. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott M P, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer J W, von Stein T, White RE, Witter J, Zavisic S: Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: impact recommendations. J Pain 2008;9:105-121. (Pubitemid 351147828)
70. Pflughaupt M, Scharnagel R, Gossrau G, Kaiser U, Koch T, Sabatowski R: Physicians' knowledge and attitudes concerning the use of opioids in the treatment of chronic cancer and non-cancer pain (in German). Schmerz 2010;24:267-275.
71. Wolfert MZ, Gilson AM, Dahl JL, Cleary JF: Opioid analgesics for pain control: Wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices. Pain Med 2010;11:425-434.
72. Upshur CC, Luckmann RS, Savageau JA: Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med 2006;21:652-655. (Pubitemid 43801498)
73. Wasan AD, Correll DJ, Kissin I, O'Shea S, Jamison RN: Iatrogenic addiction in patients treated for acute or subacute pain: a systematic review. J Opioid Manag 2006;2:16-22.
74. Gilson AM, Maurer MA, Joranson DE: State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment. J Pain 2007;8:682-691. (Pubitemid 47362841)
75. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D: Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
76. Galvez R: Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences. J Pain Palliat Care Pharmacother 2009;23:346-356.
77. Ziegler SJ, Lovrich NP: Pain relief, prescription drugs, and prosecution: a four-state survey of chief prosecutors. J Law Med Ethics 2003;31:75-100. (Pubitemid 44138849)
78. Haller DL, Acosta MC: Characteristics of pain patients with opioid-use disorder. Psychosomatics 2010;51:257-266.
79. Baldacchino A, Gilchrist G, Fleming R, Bannister J: Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addict Behav 2010;35:270-272.
80. Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson G W, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, Loeser JD, Noble M, Porter L, Rowbotham MC, Schoelles KM, Turk DC, Volinn E, von Korff MR, Webster LF, Weisner CM: Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain 2010;11: 807-829.
81. Harris JM Jr, Elliott TE, Davis BE, Chabal C, Fulginiti J V, Pine PG: Educating generalist physicians about chronic pain: live experts and online education can provide durable benefits. Pain Med 2008;9:555-563.
82. Harris JM Jr, Fulginiti J V, Gordon PR, Elliott TE, Davis BE, Chabal C, Kutob RM: KnowPain-50: a tool for assessing physician pain management education. Pain Med 2008;9:542-554.
83. Passik SD: Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc 2009;84:593-601.
84. Ehde DM, Jensen MP, Engel JM, Turner JA, Hoffman AJ, Cardenas DD: Chronic pain secondary to disability: a review. Clin J Pain 2003;19: 3-17. (Pubitemid 36043446)
85. Foley K: Pain in the elderly; in Hazzard WR, Bierman EL, Blass J P, Ettinger W, Halter J (eds): Principles of Geriatric Medicine and Gerontology, ed 3. New York, McGraw-Hill, 1994, pp 126-149.
86. Gordon RS: Pain in the elderly. JAMA 1979;241: 2191-2192.
87. Currie SR, Hodgins DC, Crabtree A, Jacobi J, Armstrong SJ: Outcome from integrated pain management treatment for recovering substance abus-ers. Pain 2003;4:91-100. (Pubitemid 36337420)
88. Fuller CM, Borrell LN, Latkin CA, Galea S, Ompad DC, Strathdee SA, Vlohov D: Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health 2005;95: 689-695. (Pubitemid 40411148)
89. Kidorf M, Brooner RK: Special section -the most critical unresolved issues associated with contemporary vocational rehabilitation for substance users: the critical relationship between employment services and patient motivation. Subst Use Misuse 2004;39:2611-2614. (Pubitemid 39612358)
90. Kidorf M, Brooner RK, King VL, Stoller KB, Wertz J: Predictive validity of cocaine, benzodiazepine, and alcohol dependence diagnoses. J Consult Clin Psychol 1998;66:168-173. (Pubitemid 28086819)
91. Kidorf M, Disney ER, King VL, Neufeld K, Beilenson PL, Brooner RK: Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend 2004;74:115-122. (Pubitemid 38501685)
92. Kidorf M, Neufeld K, Brooner RK: Combining stepped-care approaches with behavioral reinforcement to motivate employment in opioid-dependent outpatients. Subst Use Misuse 2004;39: 2215-2238.
93. Kidorf M, King VL, Neufeld K, Stoller KB, Peirce J, Brooner RK: Involving significant others in the care of opioid-dependent patients receiving methadone. J Subst Abuse Treat 2005;29:19-27. (Pubitemid 40848366)
94. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C, American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-130.
95. Manchikanti L, Benyamin R, Datta S, Vallejo R, Smith H: Opioids in chronic noncancer pain. Expert Rev Neurother 2010;10:775-789.
96. Smith HS, Kirsh KL, Passik SD: Chronic opioid therapy issues associated with opioid abuse potential. J Opioid Manag 2009;5:287-300.
97. Jamison RN, Butler SF, Budman SH, Edwards RR, Wasan AD: Gender differences in risk factors for aberrant prescription opioid use. J Pain 2010;11: 312-320.
98. Wasan AD, Butler SF, Budman SH, Fernandez K, Weiss RD, Greenfield S, Jamison RN: Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 2009;25:193-198.
99. Dersh J, Polatin PB, Gatchel RJ: Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med 2002;64:773-786.
100. Fishbain DA, Goldberg M, Meagher BR, Steele R, Rosomoff H: Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain 1986;26:181-197. (Pubitemid 16046063)
101. Harter M, Reuter K, Weisser B, Schretzmann B, Aschenbrenner A, Bengel J: A descriptive study of psychiatric disorders and psychosocial burden in rehabilitation patients with musculoskeletal diseases. Arch Phys Med Rehabil 2002;83:461-468. (Pubitemid 34275226)
102. Gureje O, Simon GE, von Korff M: A cross-national study of the course of persistent pain in primary care. Pain 2001;92:195-200. (Pubitemid 32367950)
103. Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K: Association of depression and anxiety alone and in combination with chronic musculosk-eletal pain in primary care patients. Psychosom Med 2008;70:890-897.
104. Katon W, Sullivan M, Walker E: Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma and personality traits. Ann Intern Med 2001;134: 917-925. (Pubitemid 32405701)
105. Brooner RK, King VL, Kidorf M, Schmidt C W, Bigelow GE: Psychiatric and substance use comor-bidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997;54:71-80. (Pubitemid 27044701)
106. Khantzian EJ, Treece C: DSM-III psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry 1985; 42:1067-1071. (Pubitemid 16220675)
107. Geisser ME, Cano A, Foran H: Psychometric properties of the mood and anxiety symptom questionnaire in patients with chronic pain. Clin J Pain 2006; 22:1-9. (Pubitemid 44378556)
108. Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN: Psychiatric history and psychological adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 2007;23:307-315. (Pubitemid 46650023)
109. Sullivan MD, Edlund MJ, Steffick D, Unützer J: Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005;119: 95-103. (Pubitemid 41752969)
110. Manchikanti L, Giordano J, Boswell M, Fellows B, Manchukonda R, Pampati V: Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag 2007;3: 89-100. (Pubitemid 46760149)
111. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG: Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002;17:173-179. (Pubitemid 34603843)
112. Breckenridge J, Clark JD: Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain 2003;4:344-350. (Pubitemid 37013026)
113. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, Rutter CM, Weisner C, Banta-Green C, Campbell C, von Korff M: Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry 2009;31:564-570.
114. Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB: Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006;166: 2087-2093. (Pubitemid 44631396)
115. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD: Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain 2010;26:1-8.
116. Kidner CL, Gatchel RJ, Mayer TG: MMPI disability profile is associated with degree of opioid use in chronic work-related musculoskeletal disorders. Clin J Pain 2010;26:9-15.
117. Hasin DS, Goodwin RD, Stinson FS, Grant BF: Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005;62:1097-1106. (Pubitemid 41396935)
118. Huang B, Dawson DA, Stinson FS, Hasin DS, Ruan WJ, Saha TD, Smith SM, Goldstein RB, Grant BF: Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67: 1062-1073. (Pubitemid 44230877)
119. Nedeljkovic SS, Wasan A, Jamison RN: Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain 2002;18:S39-S51. (Pubitemid 34815393)
120. Strain EC: Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clin J Pain 2002;18:S14-S27. (Pubitemid 34815391)
121. Grant BF, Stinson FS, Dawson DA, Chou S P, Dufour MC, Compton W, Pickering RP, Kaplan K: Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004;61:807-816. (Pubitemid 39031120)
122. Toblin RL, Paulozzi LJ, Logan JE, Hall AJ, Kaplan JA: Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. J Clin Psychiatry 2010;71: 491-496.
123. Brown RJ: Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol Bull 2004;130:793-812. (Pubitemid 39216583)
124. Rief W, Barsky AJ: Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005;30:996-1002. (Pubitemid 40982484)
125. McHugh PR, Slavney PR: Methods of reasoning in psychopathology: conflict and resolution. Compr Psychiatry 1982;23:197-215. (Pubitemid 12059816)
126. McHugh PR: A structure for psychiatry at the century's turn: the view from Johns Hopkins. J R Soc Med 1992;85:483-487.
127. Clark MR: Psychiatry and chronic pain: examining the interface and designing a structure for a patient-centered approach to treatment. Eur J Pain 2009; 13(suppl):95-100.
128. McHugh PR, Slavney PR: Perspectives of Psychiatry, ed 2. Baltimore, Johns Hopkins University Press, 1998.
129. Slavney PR: Perspectives on 'Hysteria'. Baltimore, Johns Hopkins University Press, 1990.
130. Reuber M, Mitchell AJ, Howlett SJ, Crimlisk HL, Grunewald RA: Functional symptoms in neurology: questions and answers. J Neurol Neurosurg Psychiatry 2005;76:307-314. (Pubitemid 40299115)
131. Clark MR: Psychogenic disorders: a pragmatic approach for formulation and treatment. Sem Neurol 2006;26:357-365.
132. Clark MR, Treisman GJ: Perspectives on pain and depression. Adv Psychosom Med 2004;25:1-27.
133. Stone J, Carson A, Sharpe M: Functional symptoms and signs in neurology: management. J Neurol Neurosurg Psychiatry 2005;76(suppl 1): i13-i21. (Pubitemid 40293038)
134. Rief W, Nanke A: Somatoform disorders in primary care and inpatient settings. Adv Psychosom Med 2004;26:144-158.
135. King VL, Peirce J, Brooner RK, Kidorf M: Predictors of treatment enrollment in syringe exchange participants. Presented at College on Problems of Drug Dependence Scientific Meeting, Quebec City, 2007.
136. Brooner RK, King V, Neufeld K, Stoller K, Peirce J, Kidorf M, Clark M, Aklin W: Integrated psychiatric services are associated with improved service delivery and better treatment response. Presented at College on Problems of Drug Dependence 70th Annual Scientific Meeting, San Juan, 2008.
137. Umbricht-Schneiter A, Ginn DH, Pabst KM, Bigelow GE: Providing medical care to methadone clinic patients: referral vs on-site care. Am J Public Health 1994;84:207-210. (Pubitemid 24138452)
138. Svikis DS, Silverman K, Hauq NA, Stitzer M, Keyser-Marcus L: Behavioral strategies to improve treatment participation and retention by pregnant drug-dependent women. Subst Use Misuse 2007;42: 1527-1535. (Pubitemid 47537305)
139. Flor H, Fydrich T, Turk DC: Efficacy of multidisci-plinary pain treatment centers: a meta-analytic review. Pain 1992;49:221-230.
140. Haythornthwaite JA: Clinical trials studying phar-macotherapy and psychological treatments alone and together. Neurology 2005;65:20-31.
141. Maruta T, Malinchoc M, Offord K P, Colligan RC: Status of patients with chronic pain 13 years after treatment in a pain management center. Pain 1998; 74:199-204. (Pubitemid 28081606)
142. Morley S, Eccleston C, Williams A: Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain 1999;80:1-13. (Pubitemid 29151684)
143. Turk DC, Okifuji A: Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol 2002;70:678-690. (Pubitemid 34649378)
144. Brooner RK, Kidorf M: Using behavioral reinforcement to improve methadone treatment participation. Sci Pract Perspect 2002;1:38-46.
145. Brooner RK, Kidorf MS, King VL, Stoller KB, Peirce JM, Bigelow GE, Kolodner K: Behavioral contingencies improve counseling attendance in an adaptive treatment model. J Subst Abuse Treat 2004; 27:223-232. (Pubitemid 40288190)
146. Brooner RK, Kidorf MS, King VL, Stoller KB, Neufeld KJ, Kolodner K: Comparing adaptive stepped care and monetary-based voucher incentives for opioid dependence. Drug Alcohol Depend 2007;88(suppl 2):S14-S23. (Pubitemid 46528063)
147. Clark MR, Stoller KB, Brooner RK: Assessment and management of chronic pain in individuals seeking treatment for opioid dependence disorder. Can J Psychiatry 2008;53:496-508.